|
METTL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.774600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.877400E-01 |
| Normal-vs-Stage2 |
9.773400E-01 |
| Normal-vs-Stage3 |
4.721600E-02 |
| Normal-vs-Stage4 |
4.667000E-01 |
| Stage1-vs-Stage2 |
6.384800E-01 |
| Stage1-vs-Stage3 |
2.462400E-02 |
| Stage1-vs-Stage4 |
2.412800E-01 |
| Stage2-vs-Stage3 |
6.452000E-02 |
| Stage2-vs-Stage4 |
4.426600E-01 |
| Stage3-vs-Stage4 |
4.372600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.813600E-01 |
| Normal-vs-AfricanAmerican |
9.700200E-01 |
| Normal-vs-Asian |
3.548200E-01 |
| Caucasian-vs-AfricanAmerican |
8.545400E-01 |
| Caucasian-vs-Asian |
2.197600E-01 |
| AfricanAmerican-vs-Asian |
3.585400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.791000E-01 |
| Normal-vs-Female |
1.693620E-02 |
| Male-vs-Female |
2.261800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.986000E-01 |
| Normal-vs-Extreme_Weight |
2.890500E-02 |
| Normal-vs-Obese |
5.482600E-01 |
| Normal-vs-Extreme_Obese |
7.388200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.586000E-01 |
| Normal_Weight-vs-Obese |
6.617800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.926200E-01 |
| Extreme_Weight-vs-Obese |
6.102200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.327800E-01 |
| Obese-vs-Extreme_Obese |
9.833600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.594100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.816600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.442400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.301700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.534300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.981700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.521700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.691900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.739900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.946650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.264000E-03 |
| Normal-VS-Type2 PRCC |
3.345000E-01 |
| Normal-VS-KIRP CIMP |
8.482800E-03 |
| Normal-VS-Unclassified PRCC |
3.268000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.087900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.899700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.162300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.939900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.248600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.575300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.015400E-01 |
| Normal-vs-N1 |
1.937950E-02 |
| Normal-vs-N2 |
8.955000E-01 |
| N0-vs-N1 |
1.973590E-01 |
| N0-vs-N2 |
8.153000E-01 |
| N1-vs-N2 |
3.573200E-01 |
|
|
